Investigators said they were able to confirm diagnoses of systemic lupus erythematosus (SLE) and thrombotic thrombocytopenic purpura (TTP) because they took a multidisciplinary approach. Thrombotic ...
Dapirolizumab pegol (DZP) associated with higher response rates using the novel Treatment Response Measure for Systemic Lupus Erythematosus ...
STAMFORD, Conn., Oct. 27, 2026 (GLOBE NEWSWIRE)-- Beeline Medicines Corporation, a clinical-stage biotechnology company focused on developing and delivering category-leading precision therapies to ...
The case involved a 69-year-old man who presented with lupus nephritis. Systemic lupus erythematosus (SLE) is most commonly associated with women of younger and middle ages, but a new case report ...
UCB and Biogen Inc. announced further data characterizing the clinical profile of dapirolizumab pegol (DZP), an investigational biologic for people living with systemic lupus erythematosus (SLE). In a ...
– Results demonstrate consistent improvements across measures of disease activity, quality of life, and pharmacodynamic markers, with a tolerable safety profile across all afimetoran dose groups – – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results